| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.465 | 40.465 | 42.193 | 48.552 | 61.822 | 74.544 | 80.891 | 87.686 | 110.168 | 137.603 |
| Total Income - EUR | 36.737 | 40.956 | 43.123 | 48.912 | 62.063 | 77.646 | 82.812 | 87.686 | 110.169 | 137.624 |
| Total Expenses - EUR | 31.924 | 43.811 | 46.073 | 45.780 | 52.532 | 63.046 | 80.060 | 66.397 | 82.920 | 84.485 |
| Gross Profit/Loss - EUR | 4.813 | -2.855 | -2.951 | 3.132 | 9.531 | 14.600 | 2.752 | 21.289 | 27.249 | 53.139 |
| Net Profit/Loss - EUR | 3.711 | -3.264 | -5.134 | 2.643 | 8.910 | 13.914 | 1.923 | 20.430 | 26.175 | 49.093 |
| Employees | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 |
Check the financial reports for the company - Prosan Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.548 | 2.206 | 17.658 | 12.240 | 7.394 | 4.431 | 2.933 | 7.876 | 9.832 | 7.318 |
| Current Assets | 4.735 | 22.588 | 10.734 | 10.889 | 14.209 | 16.443 | 37.568 | 47.014 | 44.316 | 32.729 |
| Inventories | 0 | 0 | 6 | 0 | 166 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.934 | 2.977 | 2.711 | 3.787 | 2.806 | 6.427 | 13.166 | 25.384 | 25.976 | 8.323 |
| Cash | 2.801 | 19.610 | 8.017 | 7.102 | 11.236 | 10.016 | 24.402 | 21.630 | 18.340 | 24.406 |
| Shareholders Funds | -3.742 | -6.968 | -11.985 | -9.674 | -1.127 | 12.661 | 2.026 | 20.552 | 26.296 | 49.193 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 21.025 | 31.761 | 40.377 | 32.802 | 22.730 | 8.213 | 38.474 | 34.338 | 27.879 | -9.103 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Prosan Med Srl